-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Breast cancer (BC) is the world's main cause of morbidity, mortality and disability among women.
the prognosm of treatment in BC around the world varies widely, due to a combination of factors, including access to treatment.
standards of treatment can improve the quality of treatment and improve survival;
BC's treatment guidelines were extracted from a systematic review of the literature by Dario, which assessed its development process, methodology and recommendations, and investigated the stratization of national resources.
the appropriateness of the study guidelines by selecting a measure of the capacity of the health system.
, the analysis included 49 different BC treatment guidelines, most of them in English (n-23), most of which were developed in upper-middle- and high-income countries in Europe and the United States (n-39).
quarter of the guidelines (n-11) identified resource strated approaches, mostly from resource-constrained situations.
only half of the guidelines reached the author's gender balance, and 10.2 percent were based on a multidisciplinary steering committee.
recognized that some efforts and solutions were needed in resource adaptation, mainly in low- and middle-income countries.
Overall, national guidelines appear to lack sufficient knowledge of the capacity of local health systems when developing recommendations, in other words, local health systems do not achieve the recommended treatment provided by national guidelines;
this paper, a summary analysis of BC treatment guidelines worldwide found that most of the standard treatments recommended by the guidelines do not apply to the actual situation.
, it is necessary to conduct research that establishes reasonable standards for cancer treatment, as well as to develop and disseminate new platforms for resource-appropriate guidelines.